Literature DB >> 25490047

Handling of the cotton rat in studies for the pre-clinical evaluation of oncolytic viruses.

Breanne Cuddington1, Meghan Verschoor1, Karen Mossman2.   

Abstract

Oncolytic viruses are a novel anticancer therapy with the ability to target tumor cells, while leaving healthy cells intact. For this strategy to be successful, recent studies have shown that involvement of the host immune system is essential. Therefore, oncolytic virotherapy should be evaluated within the context of an immunocompetent model. Furthermore, the study of antitumor therapies in tolerized animal models may better recapitulate results seen in clinical trials. Cotton rats, commonly used to study respiratory viruses, are an attractive model to study oncolytic virotherapy as syngeneic models of mammary carcinoma and osteosarcoma are well established. However, there is a lack of published information on the proper handling procedure for these highly excitable rodents. The handling and capture approach outlined minimizes animal stress to facilitate experimentation. This technique hinges upon the ability of the researcher to keep calm during handling and perform procedures in a timely fashion. Finally, we describe how to prepare cotton rat mammary tumor cells for consistent subcutaneous tumor formation, and how to perform intratumoral and intraperitoneal injections. These methods can be applied to a wide range of studies furthering the development of the cotton rat as a relevant pre-clinical model to study antitumor therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25490047      PMCID: PMC4354327          DOI: 10.3791/52232

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  28 in total

1.  Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication.

Authors:  Karen L Mossman; James R Smiley
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Cotton rat tumor model for the evaluation of oncolytic adenoviruses.

Authors:  Karoly Toth; Jacqueline F Spencer; Ann E Tollefson; Mohan Kuppuswamy; Konstantin Doronin; Drew L Lichtenstein; Marie C La Regina; Gregory A Prince; William S M Wold
Journal:  Hum Gene Ther       Date:  2005-01       Impact factor: 5.695

3.  Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.

Authors:  S K Mittal; Z Papp; S K Tikoo; M E Baca-Estrada; D Yoo; M Benko; L A Babiuk
Journal:  Virology       Date:  1996-08-15       Impact factor: 3.616

4.  The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1.

Authors:  Z Papp; L A Babiuk; M E Baca-Estrada
Journal:  Vaccine       Date:  1999-02-26       Impact factor: 3.641

5.  A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.

Authors:  H S Ginsberg; L L Moldawer; P B Sehgal; M Redington; P L Kilian; R M Chanock; G A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

6.  The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection.

Authors:  Marina S Boukhvalova; Jorge C G Blanco
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

7.  Mucosal immunization with recombinant adenoviruses: induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type 1 infection.

Authors:  Z Papp; D M Middleton; S K Mittal; L A Babiuk; M E Baca-Estrada
Journal:  J Gen Virol       Date:  1997-11       Impact factor: 3.891

8.  Permissiveness of human cancer cells to oncolytic bovine herpesvirus 1 is mediated in part by KRAS activity.

Authors:  Breanne P Cuddington; Karen L Mossman
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

Review 9.  Oncolytic virotherapy.

Authors:  Stephen J Russell; Kah-Whye Peng; John C Bell
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

Review 10.  Oncolytic viruses in cancer therapy.

Authors:  Markus J V Vähä-Koskela; Jari E Heikkilä; Ari E Hinkkanen
Journal:  Cancer Lett       Date:  2007-03-23       Impact factor: 8.679

View more
  2 in total

1.  Inducing Cre-lox Recombination in Mouse Cerebral Cortex Through In Utero Electroporation.

Authors:  Katherine M Bland; Zachary O Casey; Christopher J Handwerk; Z Logan Holley; George S Vidal
Journal:  J Vis Exp       Date:  2017-11-17       Impact factor: 1.355

2.  Passive narcosis for anesthesia induction in cotton rats (Sigmodon hispidus).

Authors:  Jarod M Hanson; Lydia J Anderson; Colin M Williams; Patricia Jorquera; Ralph A Tripp
Journal:  Lab Anim (NY)       Date:  2016-08-23       Impact factor: 12.625

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.